Skip to content

Clinical trials

Fallopian Tube Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Country / region: Australia Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20052
20063
20093
20102
20111
20121
20132
20141
20162
20172
20185
20191
20202
20214
20224
20237
20242
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Recruiting13
Active, not recruiting6
Terminated6
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie5
Amgen4
AstraZeneca3
Merck Sharp & Dohme LLC3
pharmaand GmbH3
Eli Lilly and Company2
MEI Pharma, Inc.2
Novartis Pharmaceuticals2
Avenzo Therapeutics, Inc.1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms52
Ovarian Neoplasms40
Carcinoma, Ovarian Epithelial24
Peritoneal Neoplasms8
Neoplasms6
Endometrial Neoplasms5
Recurrence4
Breast Neoplasms3
Neoplasm Metastasis3
Urinary Bladder Neoplasms3

Trials

Showing 26 to 50 of 52. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.